Investigation of enzymatic liver funtion in Fontan-palliated patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022517

Enrollment

Registered

2020-07-28

Start date

2020-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q20.9 K74.6

Interventions

Group 1: The aim of the study is two perform a LiMAx test in every Fontan patient, who is above 18 years of age, and routinely presents in our outpatient clinic for follow-up.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Fontan patients > 18 years

Exclusion criteria

Exclusion criteria: pediatric patients < 18 years allergic reaction to paracetamol/methacetin

Design outcomes

Primary

Measure	Time frame
The primary outcome is the result of the LiMAx test, which quantifies the enzymatic liver function.	—

Secondary

Measure	Time frame
The secondary outcomes are the changes of the liver function in dependance of the time after the Fontan operation and its correlation with sonographic parenchymal changes or serological hepatic markes.	—

Countries

Germany

Contacts

Public ContactAnastasia Schleiger

Deutsches Herzzentrum Berlin

schleiger@dhzb.de0304/5932800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026